EVGOW shows explosive revenue growth of 146% alongside dramatic balance sheet expansion, but with substantially increased liabilities outpacing asset growth.
The company demonstrates strong operational momentum with revenue more than doubling and gross profit increasing 175%, suggesting successful business execution. However, the 61% surge in total liabilities far exceeds the 20% asset growth, creating potential leverage concerns that investors should monitor closely.
EVGOW experienced exceptional top-line growth with revenue jumping 146% to $54.6M and gross profit soaring 175% to $80.8M, indicating strong operational scaling. The balance sheet expanded significantly with total assets growing 20% to $964.8M and cash increasing 29% to $151.0M, but total liabilities surged 61% to $578.9M, creating a concerning imbalance. While the deficit in stockholders' equity improved from -$256.1M to -$116.9M, the disproportionate liability growth relative to asset expansion suggests potential financial strain despite the impressive revenue performance.
Receivables surged 215% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
Strong top-line growth of 145.7% — accelerating demand or successful expansion into new markets.
Liabilities grew 60.8% — significant increase in debt or obligations, assess impact on financial flexibility.
Equity base grew 54.4% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Current assets grew 44.4% — improving short-term liquidity or inventory/receivables build.
Cash grew 28.8% — improving liquidity position supports investment and shareholder returns.
Capex increased 23.1% — ongoing investment in capacity or infrastructure for future growth.
Current liabilities rose 21.5% — increased short-term obligations, watch current ratio.
Asset base grew 20% — expansion through organic growth, acquisitions, or capital deployment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →